Are you getting the attention you need from your current central lab?

Barc Lab aspires to partner with you to develop bespoke, optimized solutions for your projects to ensure success of your treatments and improve patients’ lives. With more than 35 years of experience, 375 ongoing clinical trials, and divisions in 5 continents, we have the expertise, scientific knowledge, and technology needed to help you achieve your goals. 

THERAPEUTIC AREAS

We can meet you anywhere to deliver a unique plan for any of these key therapeutic areas, and support clients in every step of their clinical trials.

Our mission is to partner with you to bring personalized medicine to patients and
allow you to focus on what matters most: Improving healthcare and quality of life.

Oncology

As a global leader in oncology trials, we can keep you on track and beyond in this ever-evolving field.

NASH

We support the biggest phase 3 study in NASH so far, in search of a better diagnosis and treatment.

Infectious diseases

We offer flexible assays, fast and secure diagnostic opportunities, and can react quickly to new
infectious threats with the development of new tests.

Inflammatory disorders

Our specialists are committed to help you determine which tests could be implemented making your
study in inflammatory disorders more informative and less risky.

We can provide you with the solution you need by tapping on to our broad testing portfolio, ranging from Flow Cytometry, Histopathology, PK and Biomarker testing, NGS, Microbiology and any other esoteric & routing testing.

Learn more​​​​​​​

Go to article: Home | Where is my mind?Go to article: In this issueGo to article: Scandinavian Health Company InsightGo to article: Scandinavian HealthGo to article: ContentsGo to article: NSFGo to article: NewsGo to article: Daiichi JitsugyoGo to article: The pharma industry briefingGo to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: Thumbs up for esketamine sheds light on potential for ketamineGo to article: Phoenix group Company InsightGo to article: Phoenix group Go to article: Charting the life and times of the EMA as it leaves LondonGo to article: Swiss WorldCargoGo to article: Capsugel Company InsightGo to article: CapsugelGo to article: Medical cannabis in the UK: how has the roll out gone so far? Go to article: EmboCapsGo to article: Barc Lab Go to article: Drug development: the researchers driving an open-science approachGo to article: Freudenberg MedicalGo to article: AlbypharmaGo to article: The drugs fighting memory lossGo to article: Senn ChemicalsGo to article: Pharma HempGo to article: RUNLABS: empowering life science through flexible working environmentsGo to article: Spirax SarcoGo to article: Spirax Sarco Company InsightGo to article: EventsGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: B&W TekGo to article: Next issueGo to article: PfanstiehlGo to article: Centaur Clinical | Company InsightGo to article: Centaur ClinicalGo to article: Hapa Company InsightGo to article: Contract Pharmaceuticals Limited Canada